Dr. Marc Ramis Castelltort

Venture Partner

Marc is co-founder and CEO at Rejuversen AG, Ninevah Therapeutics, Senolytic Therapeutics, and partner at Chasing Science, an early-stage biomedical venture builder. Marc received his PhD in Biochemistry from the University of Oxford, a PLD from Harvard Business School, as well as a M.Sc. in Chemical Engineering and a B.Sc. in Chemistry from IQS (Barcelona).